These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32555031)

  • 21. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.
    Sorrell AD; Espenschied CR; Culver JO; Weitzel JN
    Mol Diagn Ther; 2013 Feb; 17(1):31-47. PubMed ID: 23355100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
    Raymond VM; Else T; Everett JN; Long JM; Gruber SB; Hammer GD
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E119-25. PubMed ID: 23175693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two TP53 germline mutations in a classical Li-Fraumeni syndrome family.
    van Hest LP; Ruijs MW; Wagner A; van der Meer CA; Verhoef S; van't Veer LJ; Meijers-Heijboer H
    Fam Cancer; 2007; 6(3):311-6. PubMed ID: 17318340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation.
    Courtney R; Ranganathan S
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):215-8. PubMed ID: 25374282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.
    Giacomazzi J; Selistre S; Duarte J; Ribeiro JP; Vieira PJ; de Souza Macedo G; Rossi C; Czepielewski M; Netto CB; Hainaut P; Ashton-Prolla P
    BMC Cancer; 2013 Apr; 13():187. PubMed ID: 23570263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
    Kamihara J; Rana HQ; Garber JE
    Hum Mutat; 2014 Jun; 35(6):654-62. PubMed ID: 24706533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
    Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.
    Kumamoto T; Yamazaki F; Nakano Y; Tamura C; Tashiro S; Hattori H; Nakagawara A; Tsunematsu Y
    Int J Clin Oncol; 2021 Dec; 26(12):2161-2178. PubMed ID: 34633580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Inherited p53 Mutation in the Brazilian Population.
    Achatz MI; Zambetti GP
    Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27663983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.
    Franceschi S; Spugnesi L; Aretini P; Lessi F; Scarpitta R; Galli A; Congregati C; Caligo MA; Mazzanti CM
    Carcinogenesis; 2017 Sep; 38(9):938-943. PubMed ID: 28911001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
    Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D
    Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Li-Fraumeni syndrome in Tunisian carriers with different and rare tumor phenotype: genotype-phenotype correlation.
    Sassi H; Meddeb R; Cherif MA; Nasr C; Riahi A; Hannachi S; Belguith N; M'rad R
    BMC Med Genomics; 2022 Mar; 15(1):44. PubMed ID: 35246108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Li-Fraumeni syndrome in a Turkish family.
    Karakas Z; Tugcu D; Unuvar A; Atay D; Akcay A; Gedik H; Kayserili H; Dogan O; Anak S; Devecioglu O
    Pediatr Hematol Oncol; 2010 May; 27(4):297-305. PubMed ID: 20426520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
    Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P
    Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genome research project detected TP53mutation in a girl with rhabdomyosarcoma].
    Behrendt-Møller I; Stoltze U; Hjalgrim LL; Hansen TVO; Schmiegelow K; Wadt K
    Ugeskr Laeger; 2021 Aug; 183(32):. PubMed ID: 34378529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma.
    Grayson GH; Moore S; Schneider BG; Saldivar V; Hensel CH
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):341-7. PubMed ID: 7978053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors.
    Feitosa JADS; das Chagas PF; de Sousa GR; Queiroz RGP; Cruzeiro GAV; Tone LG; Borges KS; Valera ET
    Mol Biol Rep; 2020 Aug; 47(8):6439-6443. PubMed ID: 32671623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline p53 mutation presenting as synchronous tumors.
    Cavalier ME; Davis MM; Croop JM
    J Pediatr Hematol Oncol; 2005 Aug; 27(8):441-3. PubMed ID: 16096528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular genetics of adrenocortical carcinoma.
    Barlaskar FM; Hammer GD
    Rev Endocr Metab Disord; 2007 Dec; 8(4):343-8. PubMed ID: 17934868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.